Further studies are needed to isolate the CD133+CD44+CD54+ cellular subpopulation from peripheral blood or tumor tissue of CRC patients, investigating the metastatic potential of this subpopulation by xenograft assay. The gene discussed is PROM1; the disease is colorectal carcinoma.